インスリン グラルジンの世界市場の洞察、2028年までの予測Global Insulin Glargine Market Insights, Forecast to 2028 インスリングラルギンは、ランタスなどの名称で販売されている長時間作用型の基礎インスリンアナログ製剤で、1日1回の投与により糖尿病患者の血糖値のコントロールをサポートします。本剤は、インスリンを徐放す... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリーインスリングラルギンは、ランタスなどの名称で販売されている長時間作用型の基礎インスリンアナログ製剤で、1日1回の投与により糖尿病患者の血糖値のコントロールをサポートします。本剤は、インスリンを徐放する微結晶からなり、18~26時間の長い作用時間を有し、「ピークレス」プロファイルを示します(インスリン グラルギンの添付文書による)。市場の分析と洞察インスリングラルギンの世界市場 COVID-19の大流行により、インスリングラルギンの世界市場規模は2022年に6億7000万米ドル相当と推定され、レビュー期間中にCAGR4.0%で2028年までに8億4880万米ドルに再調整されると予測されています。この健康危機による経済変化を十分に考慮し、2021年にインスリン・グラルギン世界市場の%を占めたPrefilled Injectionは、2028年までに100万米ドルの価値を持ち、ポストCOVID-19期間に修正された%のCAGRで成長すると予測されます。一方、1型糖尿病治療セグメントは、この予測期間を通して%CAGRに変更されています。 世界のインスリン グラルギンの主要なプレーヤーは、Sanofi、Eli Lillyなどです。世界の上位2社で50%近いシェアを占めています。 米国が最大の市場であり、60%以上のシェアを占め、中国、欧州がそれに続き、いずれも35%程度のシェアを有しています。 製品別では、プレフィルドシリンジが最大のセグメントで、約75%のシェアを持っています。また、用途別では、2型糖尿病の治療薬が最も多く、次いで1型糖尿病の治療薬となっています。 インスリン グラルジンの世界的な範囲とセグメント インスリン グラルギン市場は、タイプ別とアプリケーション別に分類されます。世界のインスリン グラルギン市場のプレイヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができるようになることでしょう。セグメント別分析では、2017年から2028年までのタイプ別およびアプリケーション別の売上、収益、予測に焦点を当てています。 タイプ別セグメント プレフィルドインジェクション ノンプレフィルドインジェクション 用途別セグメント 1型糖尿病治療薬 2型糖尿病治療剤 会社別 サノフィ Eli Lilly ビアトリス ガン&リー・ファーマシューティカルズ 東華東方製薬 ユナイテッド・ラボラトリーズ・インターナショナル 地域別 北アメリカ 米国 カナダ 欧州 ドイツ フランス 英国 イタリア ロシア アジア太平洋地域 中国 日本 韓国 インド オーストラリア 中国 台湾 インドネシア タイ マレーシア 中南米 メキシコ ブラジル アルゼンチン 中東・アフリカ トルコ サウジアラビア UAE 目次1 Study Coverage1.1 Insulin Glargine Product Introduction 1.2 Market by Type 1.2.1 Global Insulin Glargine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Prefilled Injection 1.2.3 Non-Prefilled Injection 1.3 Market by Application 1.3.1 Global Insulin Glargine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Type 1 Diabetes Treatment 1.3.3 Type 2 Diabetes Treatment 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Insulin Glargine Sales Estimates and Forecasts 2017-2028 2.2 Global Insulin Glargine Revenue Estimates and Forecasts 2017-2028 2.3 Global Insulin Glargine Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Insulin Glargine Sales by Region 2.4.1 Global Insulin Glargine Sales by Region (2017-2022) 2.4.2 Global Sales Insulin Glargine by Region (2023-2028) 2.5 Global Insulin Glargine Revenue by Region 2.5.1 Global Insulin Glargine Revenue by Region (2017-2022) 2.5.2 Global Insulin Glargine Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Insulin Glargine Sales by Manufacturers 3.1.1 Global Top Insulin Glargine Manufacturers by Sales (2017-2022) 3.1.2 Global Insulin Glargine Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Insulin Glargine in 2021 3.2 Global Insulin Glargine Revenue by Manufacturers 3.2.1 Global Insulin Glargine Revenue by Manufacturers (2017-2022) 3.2.2 Global Insulin Glargine Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Insulin Glargine Revenue in 2021 3.3 Global Insulin Glargine Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Insulin Glargine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Insulin Glargine Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Insulin Glargine Sales by Type 4.1.1 Global Insulin Glargine Historical Sales by Type (2017-2022) 4.1.2 Global Insulin Glargine Forecasted Sales by Type (2023-2028) 4.1.3 Global Insulin Glargine Sales Market Share by Type (2017-2028) 4.2 Global Insulin Glargine Revenue by Type 4.2.1 Global Insulin Glargine Historical Revenue by Type (2017-2022) 4.2.2 Global Insulin Glargine Forecasted Revenue by Type (2023-2028) 4.2.3 Global Insulin Glargine Revenue Market Share by Type (2017-2028) 4.3 Global Insulin Glargine Price by Type 4.3.1 Global Insulin Glargine Price by Type (2017-2022) 4.3.2 Global Insulin Glargine Price Forecast by Type (2023-2028) 5 Market Size by Application 5.1 Global Insulin Glargine Sales by Application 5.1.1 Global Insulin Glargine Historical Sales by Application (2017-2022) 5.1.2 Global Insulin Glargine Forecasted Sales by Application (2023-2028) 5.1.3 Global Insulin Glargine Sales Market Share by Application (2017-2028) 5.2 Global Insulin Glargine Revenue by Application 5.2.1 Global Insulin Glargine Historical Revenue by Application (2017-2022) 5.2.2 Global Insulin Glargine Forecasted Revenue by Application (2023-2028) 5.2.3 Global Insulin Glargine Revenue Market Share by Application (2017-2028) 5.3 Global Insulin Glargine Price by Application 5.3.1 Global Insulin Glargine Price by Application (2017-2022) 5.3.2 Global Insulin Glargine Price Forecast by Application (2023-2028) 6 North America 6.1 North America Insulin Glargine Market Size by Type 6.1.1 North America Insulin Glargine Sales by Type (2017-2028) 6.1.2 North America Insulin Glargine Revenue by Type (2017-2028) 6.2 North America Insulin Glargine Market Size by Application 6.2.1 North America Insulin Glargine Sales by Application (2017-2028) 6.2.2 North America Insulin Glargine Revenue by Application (2017-2028) 6.3 North America Insulin Glargine Market Size by Country 6.3.1 North America Insulin Glargine Sales by Country (2017-2028) 6.3.2 North America Insulin Glargine Revenue by Country (2017-2028) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Insulin Glargine Market Size by Type 7.1.1 Europe Insulin Glargine Sales by Type (2017-2028) 7.1.2 Europe Insulin Glargine Revenue by Type (2017-2028) 7.2 Europe Insulin Glargine Market Size by Application 7.2.1 Europe Insulin Glargine Sales by Application (2017-2028) 7.2.2 Europe Insulin Glargine Revenue by Application (2017-2028) 7.3 Europe Insulin Glargine Market Size by Country 7.3.1 Europe Insulin Glargine Sales by Country (2017-2028) 7.3.2 Europe Insulin Glargine Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Insulin Glargine Market Size by Type 8.1.1 Asia Pacific Insulin Glargine Sales by Type (2017-2028) 8.1.2 Asia Pacific Insulin Glargine Revenue by Type (2017-2028) 8.2 Asia Pacific Insulin Glargine Market Size by Application 8.2.1 Asia Pacific Insulin Glargine Sales by Application (2017-2028) 8.2.2 Asia Pacific Insulin Glargine Revenue by Application (2017-2028) 8.3 Asia Pacific Insulin Glargine Market Size by Region 8.3.1 Asia Pacific Insulin Glargine Sales by Region (2017-2028) 8.3.2 Asia Pacific Insulin Glargine Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 China Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 9 Latin America 9.1 Latin America Insulin Glargine Market Size by Type 9.1.1 Latin America Insulin Glargine Sales by Type (2017-2028) 9.1.2 Latin America Insulin Glargine Revenue by Type (2017-2028) 9.2 Latin America Insulin Glargine Market Size by Application 9.2.1 Latin America Insulin Glargine Sales by Application (2017-2028) 9.2.2 Latin America Insulin Glargine Revenue by Application (2017-2028) 9.3 Latin America Insulin Glargine Market Size by Country 9.3.1 Latin America Insulin Glargine Sales by Country (2017-2028) 9.3.2 Latin America Insulin Glargine Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Insulin Glargine Market Size by Type 10.1.1 Middle East and Africa Insulin Glargine Sales by Type (2017-2028) 10.1.2 Middle East and Africa Insulin Glargine Revenue by Type (2017-2028) 10.2 Middle East and Africa Insulin Glargine Market Size by Application 10.2.1 Middle East and Africa Insulin Glargine Sales by Application (2017-2028) 10.2.2 Middle East and Africa Insulin Glargine Revenue by Application (2017-2028) 10.3 Middle East and Africa Insulin Glargine Market Size by Country 10.3.1 Middle East and Africa Insulin Glargine Sales by Country (2017-2028) 10.3.2 Middle East and Africa Insulin Glargine Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 Sanofi 11.1.1 Sanofi Corporation Information 11.1.2 Sanofi Overview 11.1.3 Sanofi Insulin Glargine Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Sanofi Insulin Glargine Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Sanofi Recent Developments 11.2 Eli Lilly 11.2.1 Eli Lilly Corporation Information 11.2.2 Eli Lilly Overview 11.2.3 Eli Lilly Insulin Glargine Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Eli Lilly Insulin Glargine Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Eli Lilly Recent Developments 11.3 Viatris 11.3.1 Viatris Corporation Information 11.3.2 Viatris Overview 11.3.3 Viatris Insulin Glargine Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 Viatris Insulin Glargine Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Viatris Recent Developments 11.4 Gan&Lee Pharmaceuticals 11.4.1 Gan&Lee Pharmaceuticals Corporation Information 11.4.2 Gan&Lee Pharmaceuticals Overview 11.4.3 Gan&Lee Pharmaceuticals Insulin Glargine Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Gan&Lee Pharmaceuticals Insulin Glargine Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Gan&Lee Pharmaceuticals Recent Developments 11.5 Tonghua Dongbao Pharmaceutical 11.5.1 Tonghua Dongbao Pharmaceutical Corporation Information 11.5.2 Tonghua Dongbao Pharmaceutical Overview 11.5.3 Tonghua Dongbao Pharmaceutical Insulin Glargine Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 Tonghua Dongbao Pharmaceutical Insulin Glargine Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Tonghua Dongbao Pharmaceutical Recent Developments 11.6 United Laboratories International 11.6.1 United Laboratories International Corporation Information 11.6.2 United Laboratories International Overview 11.6.3 United Laboratories International Insulin Glargine Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 United Laboratories International Insulin Glargine Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 United Laboratories International Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Insulin Glargine Industry Chain Analysis 12.2 Insulin Glargine Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Insulin Glargine Production Mode & Process 12.4 Insulin Glargine Sales and Marketing 12.4.1 Insulin Glargine Sales Channels 12.4.2 Insulin Glargine Distributors 12.5 Insulin Glargine Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Insulin Glargine Industry Trends 13.2 Insulin Glargine Market Drivers 13.3 Insulin Glargine Market Challenges 13.4 Insulin Glargine Market Restraints 14 Key Findings in The Global Insulin Glargine Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer
Summarynsulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert). Table of Contents1 Study Coverage1.1 Insulin Glargine Product Introduction 1.2 Market by Type 1.2.1 Global Insulin Glargine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Prefilled Injection 1.2.3 Non-Prefilled Injection 1.3 Market by Application 1.3.1 Global Insulin Glargine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Type 1 Diabetes Treatment 1.3.3 Type 2 Diabetes Treatment 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Insulin Glargine Sales Estimates and Forecasts 2017-2028 2.2 Global Insulin Glargine Revenue Estimates and Forecasts 2017-2028 2.3 Global Insulin Glargine Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Insulin Glargine Sales by Region 2.4.1 Global Insulin Glargine Sales by Region (2017-2022) 2.4.2 Global Sales Insulin Glargine by Region (2023-2028) 2.5 Global Insulin Glargine Revenue by Region 2.5.1 Global Insulin Glargine Revenue by Region (2017-2022) 2.5.2 Global Insulin Glargine Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Insulin Glargine Sales by Manufacturers 3.1.1 Global Top Insulin Glargine Manufacturers by Sales (2017-2022) 3.1.2 Global Insulin Glargine Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Insulin Glargine in 2021 3.2 Global Insulin Glargine Revenue by Manufacturers 3.2.1 Global Insulin Glargine Revenue by Manufacturers (2017-2022) 3.2.2 Global Insulin Glargine Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Insulin Glargine Revenue in 2021 3.3 Global Insulin Glargine Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Insulin Glargine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Insulin Glargine Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Insulin Glargine Sales by Type 4.1.1 Global Insulin Glargine Historical Sales by Type (2017-2022) 4.1.2 Global Insulin Glargine Forecasted Sales by Type (2023-2028) 4.1.3 Global Insulin Glargine Sales Market Share by Type (2017-2028) 4.2 Global Insulin Glargine Revenue by Type 4.2.1 Global Insulin Glargine Historical Revenue by Type (2017-2022) 4.2.2 Global Insulin Glargine Forecasted Revenue by Type (2023-2028) 4.2.3 Global Insulin Glargine Revenue Market Share by Type (2017-2028) 4.3 Global Insulin Glargine Price by Type 4.3.1 Global Insulin Glargine Price by Type (2017-2022) 4.3.2 Global Insulin Glargine Price Forecast by Type (2023-2028) 5 Market Size by Application 5.1 Global Insulin Glargine Sales by Application 5.1.1 Global Insulin Glargine Historical Sales by Application (2017-2022) 5.1.2 Global Insulin Glargine Forecasted Sales by Application (2023-2028) 5.1.3 Global Insulin Glargine Sales Market Share by Application (2017-2028) 5.2 Global Insulin Glargine Revenue by Application 5.2.1 Global Insulin Glargine Historical Revenue by Application (2017-2022) 5.2.2 Global Insulin Glargine Forecasted Revenue by Application (2023-2028) 5.2.3 Global Insulin Glargine Revenue Market Share by Application (2017-2028) 5.3 Global Insulin Glargine Price by Application 5.3.1 Global Insulin Glargine Price by Application (2017-2022) 5.3.2 Global Insulin Glargine Price Forecast by Application (2023-2028) 6 North America 6.1 North America Insulin Glargine Market Size by Type 6.1.1 North America Insulin Glargine Sales by Type (2017-2028) 6.1.2 North America Insulin Glargine Revenue by Type (2017-2028) 6.2 North America Insulin Glargine Market Size by Application 6.2.1 North America Insulin Glargine Sales by Application (2017-2028) 6.2.2 North America Insulin Glargine Revenue by Application (2017-2028) 6.3 North America Insulin Glargine Market Size by Country 6.3.1 North America Insulin Glargine Sales by Country (2017-2028) 6.3.2 North America Insulin Glargine Revenue by Country (2017-2028) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Insulin Glargine Market Size by Type 7.1.1 Europe Insulin Glargine Sales by Type (2017-2028) 7.1.2 Europe Insulin Glargine Revenue by Type (2017-2028) 7.2 Europe Insulin Glargine Market Size by Application 7.2.1 Europe Insulin Glargine Sales by Application (2017-2028) 7.2.2 Europe Insulin Glargine Revenue by Application (2017-2028) 7.3 Europe Insulin Glargine Market Size by Country 7.3.1 Europe Insulin Glargine Sales by Country (2017-2028) 7.3.2 Europe Insulin Glargine Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Insulin Glargine Market Size by Type 8.1.1 Asia Pacific Insulin Glargine Sales by Type (2017-2028) 8.1.2 Asia Pacific Insulin Glargine Revenue by Type (2017-2028) 8.2 Asia Pacific Insulin Glargine Market Size by Application 8.2.1 Asia Pacific Insulin Glargine Sales by Application (2017-2028) 8.2.2 Asia Pacific Insulin Glargine Revenue by Application (2017-2028) 8.3 Asia Pacific Insulin Glargine Market Size by Region 8.3.1 Asia Pacific Insulin Glargine Sales by Region (2017-2028) 8.3.2 Asia Pacific Insulin Glargine Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 China Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 9 Latin America 9.1 Latin America Insulin Glargine Market Size by Type 9.1.1 Latin America Insulin Glargine Sales by Type (2017-2028) 9.1.2 Latin America Insulin Glargine Revenue by Type (2017-2028) 9.2 Latin America Insulin Glargine Market Size by Application 9.2.1 Latin America Insulin Glargine Sales by Application (2017-2028) 9.2.2 Latin America Insulin Glargine Revenue by Application (2017-2028) 9.3 Latin America Insulin Glargine Market Size by Country 9.3.1 Latin America Insulin Glargine Sales by Country (2017-2028) 9.3.2 Latin America Insulin Glargine Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Insulin Glargine Market Size by Type 10.1.1 Middle East and Africa Insulin Glargine Sales by Type (2017-2028) 10.1.2 Middle East and Africa Insulin Glargine Revenue by Type (2017-2028) 10.2 Middle East and Africa Insulin Glargine Market Size by Application 10.2.1 Middle East and Africa Insulin Glargine Sales by Application (2017-2028) 10.2.2 Middle East and Africa Insulin Glargine Revenue by Application (2017-2028) 10.3 Middle East and Africa Insulin Glargine Market Size by Country 10.3.1 Middle East and Africa Insulin Glargine Sales by Country (2017-2028) 10.3.2 Middle East and Africa Insulin Glargine Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 Sanofi 11.1.1 Sanofi Corporation Information 11.1.2 Sanofi Overview 11.1.3 Sanofi Insulin Glargine Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Sanofi Insulin Glargine Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Sanofi Recent Developments 11.2 Eli Lilly 11.2.1 Eli Lilly Corporation Information 11.2.2 Eli Lilly Overview 11.2.3 Eli Lilly Insulin Glargine Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Eli Lilly Insulin Glargine Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Eli Lilly Recent Developments 11.3 Viatris 11.3.1 Viatris Corporation Information 11.3.2 Viatris Overview 11.3.3 Viatris Insulin Glargine Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 Viatris Insulin Glargine Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Viatris Recent Developments 11.4 Gan&Lee Pharmaceuticals 11.4.1 Gan&Lee Pharmaceuticals Corporation Information 11.4.2 Gan&Lee Pharmaceuticals Overview 11.4.3 Gan&Lee Pharmaceuticals Insulin Glargine Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Gan&Lee Pharmaceuticals Insulin Glargine Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Gan&Lee Pharmaceuticals Recent Developments 11.5 Tonghua Dongbao Pharmaceutical 11.5.1 Tonghua Dongbao Pharmaceutical Corporation Information 11.5.2 Tonghua Dongbao Pharmaceutical Overview 11.5.3 Tonghua Dongbao Pharmaceutical Insulin Glargine Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 Tonghua Dongbao Pharmaceutical Insulin Glargine Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Tonghua Dongbao Pharmaceutical Recent Developments 11.6 United Laboratories International 11.6.1 United Laboratories International Corporation Information 11.6.2 United Laboratories International Overview 11.6.3 United Laboratories International Insulin Glargine Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 United Laboratories International Insulin Glargine Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 United Laboratories International Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Insulin Glargine Industry Chain Analysis 12.2 Insulin Glargine Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Insulin Glargine Production Mode & Process 12.4 Insulin Glargine Sales and Marketing 12.4.1 Insulin Glargine Sales Channels 12.4.2 Insulin Glargine Distributors 12.5 Insulin Glargine Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Insulin Glargine Industry Trends 13.2 Insulin Glargine Market Drivers 13.3 Insulin Glargine Market Challenges 13.4 Insulin Glargine Market Restraints 14 Key Findings in The Global Insulin Glargine Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(生化学的薬物)の最新刊レポートQYResearch社のその他分野での最新刊レポート
本レポートと同じKEY WORD(insulin)の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/21 10:26 156.13 円 165.08 円 200.38 円 |